Skip to content

PRIME P2LXFC36Recalls & reported problems

Microport Orthopedics Inc. · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M684P2LXFC361), received between Jul 14, 2020 and Jul 14, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Loss of Osseointegration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Loss of Osseointegration1

Patient problems

  • No Information1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 14, 2020Loss of Osseointegration; Loss of Osseointegration

    ALLEGEDLY, PATIENT WAS REVISED DUE TO ASEPTIC LOOSENING OF PROSTHETIC HIP.MEDWATCH NUMBER: MW5094811.

    Patient problems: No Information

    MAUDE report 10270983 ↗

Other Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented devices

All Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page